Neurowave Medical Technologies is interested in establishing licensing relationships with pharmaceutical or medical device companies with a sales presence in relevant market segments and geographies both in US and key international markets. Current market segments include:

• Chemotherapy Induced Nausea & Vomiting (CINV)
• Pregnancy Induced Nausea & Vomiting (PINV)
• Post-Operative Nausea & Vomiting (PONV)
• Motion Sickness Induced Nausea & Vomiting (MSNV)

Licensing opportunities exist in the United States and select countries internationally.

For more information on partnership and licensing opportunities, please contact Mr. Mateen Husami in our Business Development group at (312) 334-2509 or email him at mateen.h@neurowavemedical.com.